Transcriptional regulatory cascades in Runx2-dependent bone development

Tissue Engineering - Part B: Reviews

Volumn 19, Issue 3, 2013, Pages 254-263

  Liu, Tong Ming ^a,b   Lee, Eng Hin ^b  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; BONE DEVELOPMENT; COMPLEX PROCESSES; GENE REGULATORY NETWORKS; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; PROMYELOCYTIC LEUKEMIA; TRANSCRIPTIONAL MECHANISMS;

COMPLEX NETWORKS; MUSCULOSKELETAL SYSTEM; TISSUE ENGINEERING; TRANSCRIPTION FACTORS; ZINC;

BONE;

ACTIVATING TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR TWIST; ZINC FINGER PROTEIN;

BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; BONE REMODELING; CELL DIFFERENTIATION; GENE THERAPY; HEREDITY; HIGH THROUGHPUT SCREENING; HUMAN; MICROARRAY ANALYSIS; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; REVIEW;

ANIMALS; BONE DEVELOPMENT; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION; HUMANS; OSTEOGENESIS; TRANSCRIPTION, GENETIC;

EID: 84876213011     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2012.0527     Document Type: Review

References (96)

1. Van Der Plas, A., Aarden, E.M., Feijen, J.H., de Boer, A.H., Wiltink, A., Alblas, M.J., et al. Characteristics and properties of osteocytes in culture. J Bone Miner Res 9, 1697, 1994.
2. DeLise, A.M., Stringa, E., Woodward, W.A., Mello, M.A., and Tuan, R.S. Embryonic limb mesenchyme micromass culture as an in vitro model for chondrogenesis and cartilage maturation. Methods Mol Biol 137, 359, 2000.
3. Hughes, D.E., Dai, A., Tiffee, J.C., Li, H.H., Mundy, G.R., and Boyce, B.F. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 2, 1132, 1996.
4. Weinstein, R.S., Jilka, R.L., Parfitt, A.M., and Manolagas, S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102, 274, 1998.
5. Weinstein, R.S., Chen, J.R., Powers, C.C., Stewart, S.A., Landes, R.D., Bellido, T., et al. Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109, 1041, 2002.
6. Heidari, N., Miller, A.V., Hicks, M.A., Marking, C.B., and Harada, H. Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cells. Cell Death Dis 3, e349, 2012.
7. Phillips, J.E., Gersbach, C.A., Wojtowicz, A.M., and Garća, A.J. Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J Cell Sci 119(Pt 3), 581, 2006.
8. Ducy, P. Cbfa1: a molecular switch in osteoblast biology. Dev Dyn 219, 461, 2000.
9. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747, 1997.
10. Villavicencio-Lorini, P., Kuss, P., Friedrich, J., Haupt, J., Farooq, M., Tü rkmen, S., et al. Homeobox genes d11-d13 and a13 control mouse autopod cortical bone and joint formation. J Clin Invest 120, 1994, 2010.
11. D'Souza, R.N., Aberg, T., Gaikwad, J., Cavender, A., Owen, M., Karsenty, G., et al. Cbfa1 is required for epithelialmesenchymal interactions regulating tooth development in mice. Development 126, 2911, 1999.
12. Kern, B., Shen, J., Starbuck, M., and Karsenty, G. RUNX2 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 276, 7101, 2001.
13. Truong, T., Zhang, X., Pathmanathan, D., Soo, C., and Ting, K. Craniosynostosisassociated gene nell-1 is regulated by runx2. J Bone Miner Res 22, 7, 2007.
14. Bond, S.R., Lau, A., Penuela, S., Sampaio, A.V., Underhill, T.M., Laird, D.W., et al. Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature growth plate chondrocytes. J Bone Miner Res 26, 2911, 2011.
15. Pratap, J., Javed, A., Languino, L.R., Van Wijnen, A.J., Stein, J.L., Stein, G.S., et al. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 25, 8581, 2005.
16. Boumah, C.E., Lee, M., Selvamurugan, N., Shimizu, E., and Partridge, N.C. Runx2 recruits p300 to mediate parathyroid hormone's effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 gene. Mol Endocrinol 23, 1255, 2009.
17. Liu, W., Toyosawa, S., Furuichi, T., Kanatani, N., Yoshida, C., Liu, Y., et al. Overexpression of RUNX2 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155, 157, 2001.
18. Zhang, X., Yang, M., Lin, L., Chen, P., Ma, K.T., Zhou, C.Y., et al. Runx2 overexpression enhances osteoblastic differentiation and mineralization in adipose-derived stem cells in vitro and in vivo. Calcif Tissue Int 79, 169, 2006.
19. Inada, M., Yasui, T., Nomura, S., Miyake, S., Deguchi, K., Himeno, M., et al. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214, 279, 1999.
20. Takeda, S., Bonnamy, J.P., Owen, M.J., Ducy, P., and Karsenty, G. Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev 15, 467, 2001.
21. Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., et al. RUNX2, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765, 1997.
22. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., et al. Targeted disruption of RUNX2 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755, 1997.
23. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S., Albright, S., et al. Mutations involving the transcription factor RUNX2 cause cleidocranial dysplasia. Cell 89, 773, 1997.
24. Zhang, Y.W., Yasui, N., Ito, K., Huang, G., Fujii, M., Hanai, J., et al. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci USA 97, 10549, 2000.
25. Selvamurugan, N., Jefcoat, S.C., Kwok, S., Kowalewski, R., Tamasi, J.A., and Partridge, N.C. Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo. J Cell Biochem 99, 545, 2006.
26. Schmidt, K., Schinke, T., Haberland, M., Priemel, M., Schilling, A.F., Mueldner, C., et al. The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation. J Cell Biol 168, 899, 2005.
27. Dobreva, G., Chahrour, M., Dautzenberg, M., Chirivella, L., Kanzler, B., Fariñ as, I., et al. SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation. Cell 125, 971, 2006.
28. Zhou, G., Zheng, Q., Engin, F., Munivez, E., Chen, Y., Sebald, E., et al. Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA 103, 19004, 2006.
29. Lengner. C.J., Steinman, H.A., Gagnon, J., Smith, T.W., Henderson, J.E., Kream, B.E., et al. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol 172, 909, 2006.
30. Teixeira, C.C., Liu, Y., Thant, L.M., Pang, J., Palmer, G., and Alikhani, M. Foxo1, a novel regulator of osteoblast differentiation and skeletogenesis. J Biol Chem 285, 31055, 2010.
31. Hassan, M.Q., Tare, R., Lee, S.H., Mandeville, M., Weiner, B., Montecino, M., et al. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes. Mol Cell Biol 27, 3337, 2007.
32. Hassan, M.Q., Tare, R.S., Lee, S.H., Mandeville, M., Morasso, M.I., Javed, A., et al. BMP2 commitment to the osteogenic lineage involves activation of Runx2 by DLX3 and a homeodomain transcriptional network. J Biol Chem 281, 40515, 2006.
33. Lee, M.H., Kim, Y.J., Yoon, W.J., Kim, J.I., Kim, B.G., Hwang, Y.S., et al. Dlx5 specifically regulates Runx2 type II expression by binding to homeodomain-response elements in the Runx2 distal promoter. J Biol Chem 280, 35579, 2005.
34. Hassan, M.Q., Javed, A., Morasso, M.I., Karlin, J., Montecino, M., Van Wijnen, A.J., et al. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol Cell Biol 24, 9248, 2004.
35. Tribioli, C., and Lufkin, T. The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen. Development 126, 5699, 1999.
36. Bennett, C.N., Longo, K.A., Wright, W.S., Suva, L.J., Lane, T.F., Hankenson, K.D., et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci USA 102, 3324, 2005.
37. Chen, J., Yuan, K., Mao, X., Miano, J.M., Wu, H., and Chen, Y. Serum response factor regulates bone formation via IGF-1 and Runx2 signals. J Bone Miner Res 27, 1659, 2012.
38. Isenmann, S., Arthur, A., Zannettino, A.C., Turner, J.L., Shi, S., Glackin, C.A., et al. TWIST family of basic helix-loop-helix transcription factors mediate human mesenchymal stem cell growth and commitment. Stem Cells 27, 2457, 2009.
39. Yousfi, M., Lasmoles, F., and Marie, P.J. TWIST inactivation reduces RUNX2/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts. Biochem Biophys Res Commun 297, 641, 2002.
40. El Ghouzzi, V., Le Merrer, M., Perrin-Schmitt, F., Lajeunie, E., Benit, P., Renier, D., et al. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15, 42, 1997.
41. Howard, T.D., Paznekas, W.A., Green, E.D., Chiang, L.C., Ma, N., Ortiz de Luna, R.I., et al. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Sathre-Chotzen syndrome. Nat Genet 15, 36, 1997.
42. Bialek, P., Kern, B., Yang, X., Schrock, M., Sosic, D., Hong, N., et al. A twist code determines the onset of osteoblast differentiation. Dev Cell 6, 423, 2004.
43. Miraoui, H., Severe, N., Vaudin, P., Pagès, J.C., and Marie, P.J. Molecular silencing of Twist1 enhances osteogenic differentiation of murine mesenchymal stem cells: implication of FGFR2 signaling. J Cell Biochem 110, 1147, 2010.
44. Jabs, E.W., Mü ller, U., Li, X., Ma, L., Luo, W., Haworth, I.S, et al. A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75, 443, 1993.
45. Wilkie, A.O., Tang, Z., Elanko, N., Walsh, S., Twigg, S.R., Hurst, J.A., et al. Functional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification. Nat Genet 24, 387, 2000.
46. Satokata, I., Ma, L., Ohshima, H., Bei, M., Woo, I., Nishizawa, K., et al. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 24, 391, 2000.
47. Ishii, M., Merrill, A.E., Chan, Y.S., Gitelman, I., Rice, D.P., Sucov, H.M., et al. Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 130, 6131, 2003.
48. Äoub, M., Lézot, F., Molla, M., Castaneda, B., Robert, B., Goubin, G., et al. Msx2-/-transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis. Bone 41, 851, 2007.
49. Cheng, S.L., Shao, J.S., Charlton-Kachigian, N., Loewy, A.P., and Towler, D.A. MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 278, 45969, 2003.
50. Dodig, M., Tadic, T., Kronenberg, M.S., Dacic, S., Liu, Y.H., Maxson, R., et al. Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev Biol 209, 298, 1999.
51. Matsubara, T., Kida, K., Yamaguchi, A., Hata, K., Ichida, F., Meguro, H., et al. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283, 29119, 2008.
52. Cheng, S.L., Shao, J.S., Cai, J., Sierra, O.L., and Towler, D.A. Msx2 exerts bone anabolism via canonical Wnt signaling. J Biol Chem 283, 20505, 2008.
53. Chen, Z., Brand, N.J., Chen, A., Chen, S.J., Tong, J.H., Wang, Z.Y., et al. Fusion between a novel Krü ppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 12, 1161, 1993.
54. Ikeda, R., Yoshida, K., Tsukahara, S., Sakamoto, Y., Tanaka, H., Furukawa, K., et al. The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of RUNX2. J Biol Chem 280, 8523, 2005.
55. Liu, T.M., Guo, X.M., Tan, H.S., Hui, J.H., Lim, B., and Lee, E.H. Zinc-finger protein 145, acting as an upstream regulator of SOX9, improves the differentiation potential of human mesenchymal stem cells for cartilage regeneration and repair. Arthritis Rheum 63, 2711, 2011.
56. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J.M., Behringer, R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17, 2002.
57. Yagi, K., Tsuji, K., Nifuji, A., Shinomiya, K., Nakashima, K., deCrombrugghe, B., et al. Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes, J Cell Biochem 88, 1077, 2003.
58. Lapunzina, P., Aglan, M., Temtamy, S., Caparró s-Mart́n, J.A., Valencia, M., Letó n, R., et al. Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta. Am J Hum Genet 87, 110, 2010.
59. Nishio, Y., Dong, Y., Paris, M., O'Keefe, R.J., Schwarz, E.M., and Drissi, H. Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372, 62, 2006.
60. Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K., et al. NFAT and Osterix cooperatively regulate bone formation. Nat Med 11, 880, 2005.
61. Kim, S., Koga, T., Isobe, M., Kern, B.E., Yokochi, T., Chin, Y.E., et al. Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation. Genes Dev 17, 1979, 2003.
62. Zaidi, S.K., SulliVan, A.J., Medina, R., Ito, Y., Van Wijnen, A.J., Stein, J.L., et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J 23, 790, 2004.
63. Jheon, A.H., Ganss, B., Cheifetz, S., and Sodek J. Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development. J Biol Chem 276, 18282, 2001.
64. Kim, Y.J., Kim, B.G., Lee, S.J., Lee, H.K., Lee, S.H., Ryoo, H.M., et al. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation. J Cell Physiol 211, 253, 2007.
65. Hinoi, E., Fujimori, S., Wang, L., Hojo, H., Uno, K., and Yoneda, Y. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J Biol Chem 281, 18015, 2006.
66. Luan, Y., Yu, X.P., Xu, K., Ding, B., Yu, J., Huang, Y., et al. The retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the RUNX2 transcription factor thereby increasing its activity. J Biol Chem 282, 16860, 2007.
67. Jones, D.C., Wein, M.N., Oukka, M., Hofstaetter, J.G., Glimcher, M.J., and Glimcher, L.H. Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3. Science 312, 1223, 2006.
68. Yoshida, C.A., Furuichi,T., Fujita, T., Fukuyama, R., Kanatani, N., Kobayashi, S., et al. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nat Genet 32, 633, 2002.
69. Lee, K.S., Hong, S.H., and Bae, S.C. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21, 7156, 2002.
70. Hong, J.H., Hwang, E.S., McManus, M.T., Amsterdam, A., Tian, Y., Kalmukova, R., et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309, 1074, 2005.
71. Tokuzawa, Y., Yagi, K., Yamashita, Y., Nakachi, Y., Nikaido, I., Bono, H., et al. Id4, a new candidate gene for senile osteoporosis, acts as a molecular switch promoting osteoblast differentiation. PLoS Genet 6, e1001019, 2010.
72. Shimoyama, A., Wada, M., Ikeda, F., Hata, K., Matsubara, T., Nifuji, A., et al. Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol Biol Cell 18, 2411, 2007.
73. Lee, K.N., Jang, W.G., Kim, E.J., Oh, S.H., Son, H.J., Kim, S.H., et al. Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activity. J Biol Chem 287, 18888, 2012.
74. Yang, X., Matsuda, K., Bialek, P., Jacquot, S., Masuoka, H.C., Schinke, T., et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry syndrome. Cell 117, 387, 2004.
75. Poteet-Smith, C.E., Smith, J.A., Lannigan, D.A., Freed, T.A., and Sturgill, T.W. Generation of constitutively active p90 ribosomal S6 kinase in vivo. Implications for the mitogenactivated protein kinase-activated protein kinase family. J Biol Chem 274, 22135, 1999.
76. Elefteriou, F., Ahn, J.D., Takeda, S., Starbuck, M., Yang, X., Liu, X., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514, 2005.
77. Cao, H., Yu, S., Yao, Z., Galson, D.L., Jiang, Y., Zhang, X., et al. Activating transcription factor 4 regulates osteoclast differentiation in mice. J Clin Invest 120, 2755, 2010.
78. Teitelbau, S.L., and Ross, F.P. Genetic regulation of osteoclast development and function. Nat Rev Genet 4, 638, 2003.
79. Wada, T., Nakashima, T., Hiroshi, N., and Penninger, J.M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12, 17, 2006.
80. Wu, M., Hesse, E., MorVan, F., Zhang, J.P., Correa, D., Rowe, G.C., et al. Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone 44, 528, 2009.
81. Hesse, E., Kiviranta, R., Wu, M., Saito, H., Yamana, K., Correa, D., et al. Zinc finger protein 521, a new player in bone formation. Ann N Y Acad Sci 1192, 32, 2010.
82. Correa, D., Hesse, E., Seriwatanachai, D., Kiviranta, R., Saito, H., Yamana, K., et al. Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes. Dev Cell 19, 533, 2010.
83. Hesse, E., Saito,H., Kiviranta, R., Correa,D., Yamana, K.,Neff, L., et al. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity. J Cell Biol 191, 1271, 2010.
84. Seriwatanachai, D., Densmore, M.J., Sato, T., Correa, D., Neff, L., Baron, R., et al. Deletion of Zfp521 rescues the growth plate phenotype in a mouse model of Jansen metaphyseal chondrodysplasia. FASEB J 25, 3057, 2011.
85. Jeon, E.J., Lee, K.Y., Choi, N.S., Lee, M.H., Kim, H.N., Jin, Y.H., et al. Bone morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem 281, 16502, 2006.
86. Vega, R.B., Matsuda, K., Oh, J., Barbosa, A.C., Yang, X., Meadows, E., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555, 2004.
87. Schroeder, T.M., Kahler, R.A., Li, X., and Westendorf, J.J. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation. J Biol Chem 279, 41998, 2004.
88. Westendorf, J.J., Zaidi, S.K., Cascino, J.E., Kahler, R., Van Wijnen, A.J., Lian, J.B., et al. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter. Mol Cell Biol 22, 7982, 2002.
89. Jensen, E.D., Schroeder, T.M., Bailey, J., Gopalakrishnan, R., and Westendorf, J.J. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner. J Bone Miner Res 23, 361, 2008.
90. Smits, P., Bolton, A.D., Funari, V., Hong, M., Boyden, E.D., Lu, L., et al. Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N Engl J Med 362, 206, 2010.
91. Byers, B.A., Guldberg, R.E., and Garća, A.J. Synergy between genetic and tissue engineering: Runx2 overexpression and in vitro construct development enhance in vivo mineralization. Tissue Eng 10, 1757, 2004.
92. Byers, B.A., Guldberg, R.E., Hutmacher, D.W., and Garća, A.J. Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects. J Biomed Mater Res A 76, 646, 2006.
93. Wojtowicz, A.M., Templeman, K.L., Hutmacher, D.W., Guldberg, R.E., and Garća, A.J. Runx2 overexpression in bone marrow stromal cells accelerates bone formation in critical-sized femoral defects. Tissue Eng Part A 16, 2795, 2010.
94. Phillips, J.E., Hutmacher, D.W., Guldberg, R.E., and Garća, A.J. Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent. Biomaterials 27, 5535, 2006.
95. Phillips, J.E., Guldberg, R.E., and Garća, A.J. Dermal fibroblasts genetically modified to express Runx2/Cbfa1 as a mineralizing cell source for bone tissue engineering. Tissue Eng 13, 2029, 2007.
96. Phillips, J.E., Burns, K.L., Le Doux, J.M., Guldberg, R.E., and Garća, A.J. Engineering graded tissue interfaces. Proc Natl Acad Sci USA 105, 12170, 2008.